{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T03:15:45Z","timestamp":1786850145772,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1053\/j.seminhematol.2022.02.002","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T23:33:12Z","timestamp":1644276792000},"page":"72-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Epidemiology of VITT"],"prefix":"10.1053","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6053-689X","authenticated-orcid":false,"given":"Menaka","family":"Pai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2022.02.002_bib0001","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.thromres.2021.10.007","article-title":"VIPIT versus VITT: what's in a name?","volume":"207","author":"Warkentin","year":"2021","journal-title":"Thromb Res"},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0002","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.280154","article-title":"Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines","author":"Michalik","year":"2022","journal-title":"Haematologica"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.02.002_bib0003","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.7326\/M21-2680","article-title":"Thrombosis after vaccination with messenger RNA-1273: is this vaccine-induced thrombosis and thrombocytopenia or thrombosis with thrombocytopenia syndrome?","volume":"174","author":"Pishko","year":"2021","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.02.002_bib0004","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.7326\/L21-0244","article-title":"Thrombosis with thrombocytopenia after the messenger RNA-1273 vaccine","volume":"174","author":"Sangli","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0005","unstructured":"Case series of thrombosis with thrombocytopenia syndrome following COVID-19 vaccination\u2014United States, December 2020\u2013August 2021 | medRxiv [Internet]. [cited 2022 Jan 29]. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2021.11.10.21266063v1."},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0006","unstructured":"Thrombosis and thrombocytopenia after HPV vaccination - Johansen - - Journal of Thrombosis and Haemostasis - Wiley Online Library [Internet]. [cited 2022 Jan 29]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jth.15604."},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0007","article-title":"Updated brighton collaboration case definition for thrombosis with thrombocytopenia syndrome (TTS) [Internet]","author":"Chen","year":"2021","journal-title":"Brighton Collaboration"},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0008","first-page":"e12596","article-title":"Res Pract Thromb Haemost","volume":"5","author":"Page","year":"2021"},{"issue":"12","key":"10.1053\/j.seminhematol.2022.02.002_bib0009","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1055\/a-1585-6182","article-title":"Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"121","author":"Gabarin","year":"2021","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1053\/j.seminhematol.2022.02.002_bib0010","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/jth.15346","article-title":"Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)","volume":"19","author":"Thaler","year":"2021","journal-title":"J Thromb Haemost JTH"},{"issue":"22","key":"10.1053\/j.seminhematol.2022.02.002_bib0011","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1182\/bloodadvances.2021005388","article-title":"VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis","volume":"5","author":"Kennedy","year":"2021","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0012","unstructured":"Most cases of Thrombosis and Thrombocytopenia Syndrome (TTS) post ChAdOx-1 nCov-19 are Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) - The Lancet Regional Health \u2013 Europe [Internet]. [cited 2022 Jan 29]. Available from: https:\/\/www.thelancet.com\/journals\/lanepe\/article\/PIIS2666-7762(21)00260-X\/fulltext."},{"issue":"22","key":"10.1053\/j.seminhematol.2022.02.002_bib0013","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMc2112974","article-title":"Vaccine-induced thrombocytopenia with severe headache","volume":"385","author":"Salih","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.02.002_bib0014","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0015","unstructured":"Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany - ScienceDirect [Internet]. [cited 2022 Jan 29]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2666776221002568?via%3Dihub."},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0016","article-title":"Australian government department of health","year":"2021","journal-title":"Therapeutic Goods Administration"},{"issue":"22","key":"10.1053\/j.seminhematol.2022.02.002_bib0017","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0018","unstructured":"Coronavirus vaccine - weekly summary of Yellow Card reporting [Internet]. GOV.UK. [cited 2021 May 1]. Available from: https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions\/coronavirus-vaccine-summary-of-yellow-card-reporting."},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0019","series-title":"ACIP Meeting","article-title":"Updates to the benefit\/risk assessment for Janssen COVID-19 vaccines: applying the evidence to recommendation framework","author":"Oliver","year":"2021"},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0020","unstructured":"Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca\/COVISHIELD Adenovirus Vector COVID-19 Vaccines [Internet]. Ontario COVID-19 Science Advisory Table. [cited 2022 Jan 30]. Available from: https:\/\/covid19-sciencetable.ca\/sciencebrief\/risk-of-vaccine-induced-thrombotic-thrombocytopenia-vitt-following-the-astrazeneca-covishield-adenovirus-vector-covid-19-vaccines\/."},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.002_bib0021","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S2352-3026(21)00306-9","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"9","author":"Klok","year":"2022","journal-title":"Lancet Haematol"},{"issue":"22","key":"10.1053\/j.seminhematol.2022.02.002_bib0022","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2022.02.002_bib0023","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","article-title":"Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia","volume":"108","author":"Warkentin","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2022.02.002_bib0024","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2022.02.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1053\/j.seminhematol.2022.02.002_bib0026","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJMc2111305","article-title":"No correlation between anti-PF4 and anti\u2013SARS-CoV-2 antibodies after ChAdOx1 nCoV-19 vaccination","volume":"385","author":"Uzun","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1053\/j.seminhematol.2022.02.002_bib0027","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.2021012938","article-title":"Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196322000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196322000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:28:40Z","timestamp":1758522520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196322000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0037196322000051"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2022.02.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of VITT","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2022.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}